Marco Ledri

Medicin och livsvetenskap

1. Optogenetics 100%
2. Interneurons 91%
3. Epilepsy 67%
4. Seizures 65%
5. Neuropeptide Y 58%
6. Neurons 57%
7. Synapses 56%
8. Hippocampus 53%
9. GABAergic Neurons 32%
10. Cannabinoid Receptor CB1 29%
11. Dentate Gyrus 28%
12. Genetic Therapy 28%
13. Parvalbumins 28%
14. Temporal Lobe Epilepsy 26%
15. gamma-Aminobutyric Acid 25%
16. Endocannabinoids 24%
17. Brain 23%
18. Synaptic Transmission 22%
19. Galanin 21%
20. protectin D1 18%
21. Action Potentials 17%
22. Cannabinoids 16%
23. Light 16%
24. Stem Cells 16%
25. Drug Resistant Epilepsy 16%
26. Genes 16%
27. docosapentaenoic acid 16%
28. Clustered Regularly Interspaced Short Palindromic Repeats 15%
29. glyceryl 2-arachidonate 14%
30. Neuronal Plasticity 14%
31. Human Embryonic Stem Cells 13%
32. Neuropeptides 13%
33. Glial Cell Line-Derived Neurotrophic Factor 13%
34. Cholecystokinin 12%
35. Nervous System Diseases 12%
36. Technology 12%
37. Neurodevelopmental Disorders 11%
38. Psychology Transfer 11%
39. Long-Term Potentiation 11%
40. Induced Pluripotent Stem Cells 11%
41. Pyramidal Cells 10%
42. Neuroepithelial Cells 10%
43. Chlorides 10%
44. Stem Cell Transplantation 10%
45. G-Protein-Coupled Receptors 10%
46. In Vitro Techniques 9%
47. Status Epilepticus 9%
48. Galanin Receptors 9%
49. Therapeutics 9%
50. Brain Diseases 9%